← FDA DRUG APPROVALS

FDA ANDA · ANDA206588

DEXTROAMPHETAMINE SULFATE

Sponsor: NESHER PHARMS

APPLICATION
ANDA206588
TYPE
ANDA
ORIGINAL APPROVAL
2016-03-28
LATEST ACTION
2022-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DEXTROAMPHETAMINE SULFATEDiscontinued
DEXTROAMPHETAMINE SULFATE 10MG · TABLET · ORAL
DEXTROAMPHETAMINE SULFATEDiscontinued
DEXTROAMPHETAMINE SULFATE 5MG · TABLET · ORAL

Approval history

2022-02-25Labeling · Supplement 4 · standardAP
2017-02-09Labeling · Supplement 2 · standardAP
2016-03-28UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →